Erenumab
Based on 1 publication(s) in Google Scholar
Erenumab (AMG-334) is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene-related peptide (CGRP) receptor. Erenumab prevents the increase in dermal blood flow in cynomolgus monkeys. Erenumab can be used in the research of episodic migraine.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 98.88%
- CAS 番号: 1582205-90-0
- 分子量:145.5 kDa
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
MedChemExpress（MCE）の使用を引用している文献 Erenumab
More
生物活性
Human IgG2 lambda
Human
CALCRL/CGRPR
Erenumab (1-100 nM) competitively inhibits the vasodilatory effect induced by aCGRP, with a pA2 of 9.00 in cerebral arteries and an apparent pKB of 7.50 in meningeal arteries, indicating that it is more potent in cerebral arteries[2].
Erenumab (0.5 pM-10 μM, 3 h) competes with [125I]-CGRP for binding to human CGRP receptors, with a Ki value of 0.02 nM. In cell-based functional assays (human CGRP receptors), AMG 334 fully inhibits CGRP-stimulated cyclic adenosine monophosphate (cAMP) production, with an IC50 of 2.3 nM[3].
Erenumab (0.5 pM-10 μM, 3 h) exhibits antagonistic potency at cynomolgus monkey CGRP receptors, with an IC50 of 5.7 nM[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Cynos[1]
-
Dosage:0.1, 0.3, 3,
10, and 30 mg/kg -
Administration:i.v., single
-
Result:Dose
dependently prevented capsaicin-induced increases in dermal blood flow (DBF).
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Human IgG2 lambda
ELISA, FACS, Functional assay
化学情報
-
CAS 番号 1582205-90-0
-
性状 Liquid
-
分子量 145.5 kDa
-
Color Colorless to light yellow
-
SMILES
[Erenumab]
-
別名
AMG-334
-
輸送条件
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Int J Biol Macromol
Mimotopes of calcitonin gene-related peptide (CGRP) screened from Fv-antibody library: antagonists to CGRP receptor. [Abstract]2025 Dec;334(Pt 2):149080. PMID: 41253226
純度とドキュメンテーション
-
データシート (261 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
参考文献
[1]. Shi L, et al. Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor. J Pharmacol Exp Ther. 2016 Jan;356(1):223-31. [Content Brief]
[2]. Reuter U, et al. Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial. Cephalalgia. 2022;42(2):108-118. [Content Brief]
[3]. Ohlsson L, et al. Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries. Cephalalgia. 2019;39(14):1745-1752. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Erenumab 関連分類
HY-P9938 関連分類
Powered by Bioz